BridgeBio Oncology Therapeutics, Inc. BBOT
NASDAQ · United States · Health Technology
$3.89-0.05 (-1.27%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.71 | -0.57 | -24.8% | $0 | — | +1.5%$9.28→$9.42 |
| Q1 2026 | 2026-05-12 | -0.53 | -0.51 | -3.9% | — | — | +2.4%$7.89→$8.08 |
| Q4 2025 | 2026-03-05 | -0.49 | -0.66 | +25.8% | — | — | +2.5%$10.17→$10.42 |
| Q3 2025 | 2025-11-12 | -1.03 | -0.41 | -151.2% | — | — | -2.9%$12.75→$12.38 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.